Join MitoAction and Dr. Alex Dorenbaum, Chief Medical Officer at Reneo Pharmaceuticals, as they discuss the Stride Study …
Pyruvate Dehydrogenase, Compassionate Use & Clinical Trials
This presentation will discuss lactic acidosis and focus on pyruvate dehydrogenase as a case study to explore how …
Stealth BioTherapeutics & NuPOWER Trial Update
Stealth’s lead investigational compound elamipretide targets the inner mitochondrial membrane, binds to cardiolipin and …
LC-Fatty Acid Oxidation Disorders: Recent Updates on the REN001 Study
There was much discussion about current research in FAODs at the 2022 International Metabolic conference. Reneo …
MELAS Spectrum Disorders and Sonlicromanol: Progress Update
Join MitoAction and Dr. Jan Smeitink, CEO of Khondrion for our our March Expert Series presentation. MELAS spectrum …
- 1
- 2
- 3
- …
- 5
- Next Page »
